Riskpilot← Back to searchSign inGet full accessASKØYBRUA APOTEK AS
ASActiveOrg 923154949Holmedalen 2C, 5300 KleppestøRetail sale of pharmaceutical products · NACE 4773Est. 20199 employees
Revenue 2024
NOK 25,7M
+13% vs 2023
EBITDA margin
3.7%
+50% vs 2023
Equity ratio
0.8%
Financial strength
Net profit 2024
NOK 592K
+74% vs 2023
| Revenue | NOK 25,7M | +13% |
| EBITDA | NOK 947K | +50% |
| Net profit | NOK 592K | +74% |
| Total assets | NOK 3,7M | -45% |
| Equity | NOK 30K | -37% |
| Employees | 9 | — |
Legal name
ASKØYBRUA APOTEK AS
Org number
923154949
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
2. august 2019
Share capital
NOK 30 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Eie og drive apotek, herunder konsulenttjenester innenfor apotekerbransjen og lege- og helserelaterte produkter, samt øvrig virksomhet i tilknytning til dette
Address
Holmedalen 2C, 5300 Kleppestø
Phone
+4756143510
Email
apotek1.askoybroen@apotek1.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8 653 | 13 982 | 16 037 | 22 670 | 25 685 |
| Staff expenses | −1 815 | −2 577 | −3 236 | −3 858 | −4 044 |
| EBITDA | 165 | 351 | 239 | 633 | 947 |
| Depreciation & amort. | −222 | −178 | −145 | −141 | −147 |
| EBIT | −58 | 173 | 94 | 492 | 800 |
| Net financials | −79 | −71 | −62 | −55 | −26 |
| Profit before tax | −137 | 102 | 32 | 437 | 774 |
| Tax | −0 | −0 | −0 | 97 | 183 |
| Net profit | −137 | 102 | 32 | 340 | 592 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 353 | 4 378 | 5 177 | 6 745 | 3 711 |
| Equity | −426 | −324 | −292 | 48 | 30 |
| Long-term debt | 1 448 | 1 196 | 944 | 719 | 13 |
| Short-term debt | 4 332 | 3 506 | 4 525 | 5 978 | 3 668 |
| Total debt | 5 780 | 4 702 | 5 470 | 6 697 | 3 681 |
EBITDA margin
3.7%
This company
15.8%
Market median
-77% vs market
20202024
Equity ratio
0.8%
This company
38.2%
Market median
-98% vs market
20202024
Return on equity
1973.0%
This company
18.4%
Market median
+10623% vs market
20202024
Net profit margin
2.3%
This company
8.1%
Market median
-72% vs market
20202024
Asset turnover
6.92×
This company
1.12×
Market median
+518% vs market
20202024
Debt / equity
122.69×
This company
0.62×
Market median
-19689% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AJ Chief Executive Officer | Chief Executive Officer | 2020 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 80% | 80% | 2022 | |
| Company | 20% | 20% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Søvdsnes Holding As
ASKØYBRUA APOTEK AS Board members of ASKØYBRUA APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Asko Juhana Heikkilä | Chief Executive Officer | 0 companies |